HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ivan Jurkovic Selected Research

Sigma-1 Receptor

1/2022Safety and efficacy of fluvoxamine in COVID-19 ICU patients: An open label, prospective cohort trial with matched controls.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ivan Jurkovic Research Topics

Disease

1COVID-19
01/2022
1Renal Cell Carcinoma (Grawitz Tumor)
01/2003
1Carcinoid Tumor (Carcinoid)
01/2003
1renal Oncocytoma
01/2003

Drug/Important Bio-Agent (IBA)

1Fluvoxamine (Luvox)FDA LinkGeneric
01/2022
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2022
1Sigma-1 ReceptorIBA
01/2022

Therapy/Procedure

1Therapeutics
01/2022
1Nephrectomy
01/2003